Trade Mark Journal No.2026/005 30 January 2026

UK00004325245 16 January 2026 (9,42,44)

Mark 1

Image for mark UK00004325245_1of3 imu

Mark 2

Image for mark UK00004325245_2of3

Mark 3

Image for mark UK00004325245_3of3
Class 9
Apparatus and instruments for detecting, measuring, analysing and testing biomarkers in samples; apparatus and instruments for processing and analysing biological samples; computer software and computer hardware for processing and analysing biological samples and biomarkers; computer software for mapping and profiling the human immune system; bioinformatics software for processing and analysing biological samples and biomarkers; bioinformatics software for mapping and profiling the human immune system; computer software platforms for processing and analysing biological samples; computer software platforms for mapping and profiling the human immune system; computer software platforms for connecting medical experts and patients on a personalised customisable platform; mobile applications for processing and analysing biological samples and biomarkers; mobile applications for mapping and profiling the human immune system; computer application software for enabling the exchange of healthcare information and collaboration among care providers; downloadable applications for use with clinical diagnostic tests; downloadable software applications for the purpose of wellness assessment for use with clinical diagnostic tests; downloadable electronic publications in the nature of scientific publications and downloadable reports all in the fields of health and wellbeing; medical research apparatus and instruments for detecting, measuring, analysing and testing biomarkers in samples; parts and fittings for all the aforesaid goods.
Class 42
Medical research services; medical research laboratory services; biological research, clinical research and medical research; provision of information and data relating to medical research and development; scientific research for medical purposes; consultancy in relation to the aforesaid services; software as a service services featuring software for processing and analysing biological samples and biomarkers; software as a service services featuring software for mapping and profiling the human immune system; platform as a service featuring software services for processing and analysing biological samples and biomarkers; platform as a services featuring software services for mapping and profiling the human immune system; providing a software platform for providing scientific analysis and informational reports based on the results of laboratory testing; hosting a web portal enabling users to record, view and retrieve health outcomes and determine health plans; information advice and consultancy in relation to all the aforesaid services.
Class 44
Medical services; human healthcare services; provision of information relating to prevention, diagnosis, treatment and identification of medical and health disorders or imbalances; medical and health services relating to blood testing; medical testing services; diagnostic medical services and advice; medical advisory services; telemedicine services; providing medical information in the field of health and wellbeing; provision of information and data relating to clinical diagnostic tests; preparation of reports in connection with medical matters; issuing medical reports, namely, providing individual medical examination reports; medical diagnosis services; medical evaluation services; personalised health and wellbeing advice; advisory services with respect to health, including lifestyle counselling based on individual health outcomes; providing medical health risk assessments; personalised health and wellbeing advice; consultancy, advice and information related to the aforesaid services. .

Melio Healthcare Limited

Representative: Stratagem Intellectual Property Management Limited